project id: TCGA-BLCA; case submitter id: TCGA-GV-A3QF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.4; age at index: 79; days to birth: -28890; days to death: 617; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1932; age at diagnosis: 28890; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 232.0; icd 10 code: C67.3; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Anterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Anterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to collection: 149; days to sample procurement: 0; initial weight: 250.0; portion submitter id: TCGA-GV-A3QF-01A-31; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;